Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilot© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 86971 refers to the pretreatment of red blood cells (RBCs) specifically for the purposes of detecting, identifying, and/or testing compatibility for RBC antibodies. This procedure involves incubating the red blood cells with enzymes, which enhances the ability to analyze the reaction between the RBCs and any suspected drugs present in the bloodstream. The process is critical in situations where a blood sample has tested positive for an antibody related to a drug, as it allows healthcare professionals to ascertain the presence of that drug and its potential interactions. By utilizing this code, medical coders can accurately document the enzymatic treatment of the blood sample prior to further examination, ensuring that the testing process is properly recorded and billed. It is important to note that if the components of the blood are separated before testing, a different code, 86972, should be used instead.
© Copyright 2026 Coding Ahead. All rights reserved.
The procedure associated with CPT® Code 86971 is indicated in specific clinical scenarios where there is a need to detect and identify antibodies against red blood cells, particularly in the context of drug interactions. The following conditions may warrant the use of this procedure:
The procedure for CPT® Code 86971 involves several critical steps to ensure accurate detection and identification of RBC antibodies. The following procedural steps are outlined:
Post-procedure care following the use of CPT® Code 86971 typically involves monitoring the patient for any adverse reactions, especially if the procedure is part of a larger diagnostic or therapeutic process. The results of the antibody detection and identification will guide further clinical decisions, including potential adjustments to medication or the need for additional testing. It is essential for healthcare providers to document the findings accurately and communicate them to the relevant medical team members for appropriate follow-up care.
| Short Descr | RBC PRETX INCUBATJ W/ENZYMES | Medium Descr | PRETX RBC ANTIBODY INCUBAT W/ENZYMES EACH | Long Descr | Pretreatment of RBCs for use in RBC antibody detection, identification, and/or compatibility testing; incubation with enzymes, each | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | STV-Packaged Codes | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1H - Lab tests - other (non-Medicare fee schedule) | MUE | 1 | CCS Clinical Classification | 235 - Other Laboratory |
| 90 | Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number. |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2013-01-01 | Changed | Short Descriptor changed. |
| 1993-01-01 | Added | First appearance in code book in 1993. |
Get instant expert-level medical coding assistance.